Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-18

FDA Approved: FINGOLIMOD — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's original application for fingolimod, allowing a generic version of the multiple sclerosis treatment to reach the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)